Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new footer line 'Revision: v3.4.2' and removed the previous downtime/operating-status notice as well as the older 'Revision: v3.4.1' text.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates include a visible 'Show glossary' option and capitalization tweaks such as 'Last Update Submitted that Met QC Criteria'. The changes also adjust wording to 'No FEAR Act Data' and add a new footer revision tag 'Revision: v3.4.0'.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 on the page, indicating a minor update to revision history that does not affect the trial data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now shows Revision: v3.3.3 in place of Revision: v3.3.2, and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded a note that PubMed publications are automatically populated for this study and updated the page revision from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.